Importantly, we showed that two IRE-1α RNase inhibitors STF and 4μ8c markedly ameliorated the diabetic conditions and protected β-cell viability and function in Akita mice, thus revealing IRE-1α as an important target in β-cell protection and diabetes therapy. Here, ERN1 is linked to diabetes mellitus.